Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) has issued an update.
MicroPort CardioFlow Medtech Corporation has issued a supplemental announcement to clarify the deadline for lodging share transfers to qualify for voting rights at the upcoming Extraordinary General Meeting (EGM). The corrected deadline is now set for 4:30 p.m. on Tuesday, December 9, 2025, instead of the previously stated date. This clarification ensures stakeholders are accurately informed about the voting process, maintaining transparency and trust in the company’s governance.
The most recent analyst rating on (HK:2160) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on MicroPort CardioFlow Medtech Corp. stock, see the HK:2160 Stock Forecast page.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corporation is a company incorporated in the Cayman Islands, focusing on the medical technology industry. It specializes in developing and manufacturing cardiovascular devices, aiming to provide innovative solutions for heart-related medical conditions.
Average Trading Volume: 7,235,122
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.65B
See more insights into 2160 stock on TipRanks’ Stock Analysis page.